209 related articles for article (PubMed ID: 35902050)
1. Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem.
Koo J; Auletta JJ; Hartley DM; Huber J; Jaglowski S; Kapadia M; Kusnier K; Lehmann L; Maakaron J; Myers KC; Pai A; Parker L; Phelan R; Sper C; Rotz SJ; Dandoy CE
Transplant Cell Ther; 2022 Nov; 28(11):737-746. PubMed ID: 35902050
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic stem cell transplantation during the COVID-19 pandemic with reference to EBMT recommendation].
Atsuta Y; Doki N
Rinsho Ketsueki; 2021; 62(2):106-114. PubMed ID: 33678769
[TBL] [Abstract][Full Text] [Related]
4. Distress in a Pandemic: Association of the Coronavirus Disease-2019 Pandemic with Distress and Quality of Life in Hematopoietic Stem Cell Transplantation.
Amonoo HL; Topping CEW; Clay MA; Reynolds MJ; Rice J; Harnedy LE; Longley RM; LeBlanc TW; Greer JA; Chen YB; DeFilipp Z; Lee SJ; Temel JS; El-Jawahri A
Transplant Cell Ther; 2021 Dec; 27(12):1015.e1-1015.e7. PubMed ID: 34536571
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.
Maurer K; Saucier A; Kim HT; Acharya U; Mo CC; Porter J; Albert C; Cutler C; Antin JH; Koreth J; Gooptu M; Romee R; Wu CJ; Soiffer RJ; Nikiforow S; Jacobson C; Ho VT
Blood Adv; 2021 Feb; 5(3):861-871. PubMed ID: 33560397
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
[TBL] [Abstract][Full Text] [Related]
7. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
[TBL] [Abstract][Full Text] [Related]
8. The impact of the COVID-19 virus and pandemic on healthcare utilization, access, delivery, experiences, and outcomes in the spinal cord injuries/dysfunction population: A scoping review study.
Senthinathan A; Cimino S; Jaglal SB; Craven BC; Tu K; Guilcher S
PLoS One; 2024; 19(2):e0297384. PubMed ID: 38386642
[TBL] [Abstract][Full Text] [Related]
9. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
[TBL] [Abstract][Full Text] [Related]
11. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients.
Lafarge A; Mabrouki A; Yvin E; Bredin S; Binois Y; Clere-Jehl R; Azoulay E
Curr Opin Crit Care; 2022 Feb; 28(1):83-89. PubMed ID: 34813523
[TBL] [Abstract][Full Text] [Related]
13. Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the World Marrow Donor Association.
Pawson R; Anthias C; Cody M; Fechter M; Fournier D; O'Flaherty E; Oliviera D; van Eerden E; Mengling T
Transplant Cell Ther; 2023 Aug; 29(8):522.e1-522.e5. PubMed ID: 37271343
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group.
Xu LP; Lu DP; Wu DP; Jiang EL; Liu DH; Huang H; Sun ZM; Li NN; Liu QF; Zhang X; Lai YR; Song YP; Song XM; Liu SX; Zhang YC; Luo CJ; Xia LH; Niu T; Yu Y; Zhang XH; Tang XW; Luo Y; Huang XJ;
Transplant Cell Ther; 2023 Feb; 29(2):136.e1-136.e7. PubMed ID: 36402457
[TBL] [Abstract][Full Text] [Related]
15. Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
Macková J; Hainz P; Kryštofová J; Roubalová K; Šťastná-Marková M; Vaníková Š; Musil J; Vydra J; Němečková Š
Leuk Res; 2023 Jul; 130():107314. PubMed ID: 37216792
[TBL] [Abstract][Full Text] [Related]
16. Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices.
Ardura M; Hartley D; Dandoy C; Lehmann L; Jaglowski S; Auletta JJ;
Biol Blood Marrow Transplant; 2020 Jul; 26(7):e147-e160. PubMed ID: 32339662
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report.
Jarmoliński T; Matkowska-Kocjan A; Rosa M; Olejnik I; Gorczyńska E; Kałwak K; Ussowicz M
Pediatr Transplant; 2021 Aug; 25(5):e13875. PubMed ID: 32949079
[TBL] [Abstract][Full Text] [Related]
18. [COVID-19 vaccination for allogeneic hematopoietic stem cell recipients].
Nagafuji K
Rinsho Ketsueki; 2022; 63(9):1067-1077. PubMed ID: 36198531
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 on the Nile: Review on the Management and Outcomes of the COVID-19 Pandemic in the Arab Republic of Egypt from February to August 2020.
Gaye YE; Agbajogu C; El Oakley R
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567519
[TBL] [Abstract][Full Text] [Related]
20. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
